Abstract: This invention comprises a water free liquid composition comprising Teriparatide for transmucosal delivery that adheres to mucosa after coming in contact with mucosal surface and a system of making dosage form from the same and delivering to mucous membrane at various locations though liquid drops, capsule or tablets. The liquid composition is characterized by being a monophasic composition. The liquid monophasic composition comprises a non-aqueous liquid as carrier, a penetration enhancer/permeation enhancer, stabilizer and a surfactant. The liquid composition of Teriparatide intended to be dispensed to a mucosal membrane of oral/buccal cavity as liquid drops, or of oral/buccal cavity or nasal cavity as an oral or nasal spray or of oral/buccal cavity as an oral film; or of a part of alimentary canal as incorporated in a capsule or a tablet as an ingredient.